The application segmentation delineates the pheromones market into five principal end‑uses, each reflecting unique demand drivers and revenue contributions. Human health applications, encompassing therapeutic and diagnostic products, represent the largest share at approximately 35%, driven by rising interest in non‑invasive treatments and personalized medicine. Veterinary uses, such as reproductive control and disease monitoring in livestock, account for about 25%, supported by intensifying animal husbandry practices. Agricultural applications, including crop pollination enhancers and growth regulators, contribute 20% of market value, reflecting the sector's push toward sustainable yield optimization. Pest control solutions, leveraging pheromone traps and mating disruption, hold a 15% share, benefiting from integrated pest management adoption. Finally, research and development activities, which involve basic science and assay development, occupy the remaining 5%. This market taxonomy clarifies how each application segment underpins overall market size and informs strategic resource allocation.